Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Kidney360|October 17, 2022
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKDPablo E Pergola, Chaim Charytan, Dustin J Little, et al.
Current Medical Research and Opinion|March 11, 2008
The association of darbepoetin alfa with hemoglobin and health-related quality of life in patients with chronic kidney disease not receiving dialysisAli K Abu-Alfa, Lance Sloan, Chaim Charytan, et al.
Kidney International|September 17, 2005
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patientsBruce S Spinowitz, Michael H Schwenk, Paula M Jacobs, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2016
Introduction of Biosimilar Therapeutics Into Nephrology Practice in the United States: Report of a Scientific Workshop Sponsored by the National Kidney FoundationJay B Wish, Chaim Charytan, Glenn M Chertow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysisChaim Charytan, Jack W Coburn, Michel Chonchol, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 24, 2008
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study resultsSteven Fishbane, Warren B Shapiro, Dalila B Corry, et al.
Kidney International|August 26, 2004
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimensGeorge R Aronoff, William M Bennett, Samuel Blumenthal, et al.
Vaccine|April 21, 2023
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney diseaseMatthias Girndt, Patricia Houser, Roberto Manllo-Karim, et al.
Kidney International|August 18, 2005
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HClKevin J Martin, Harald Jüppner, Donald J Sherrard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2008
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysisMichel Chonchol, Francesco Locatelli, Hanna E Abboud, et al.
Pageof 3